ee7d3c244e66268da2443fb5766cf537

ANTIBIOTICOS AMINOGLUCOSIDOS:

AMINOGLYCOSIDE ANTIBIOTICS:
DISTRIBUIDORA Y COMERCIALIZADORA DIZAR LTDA.·II·Colombia INVIMA·Expires June 14, 2033
Device classification
Risk class / Clase de Riesgo
II
Product type (Spanish)
REACTIVO DIAGNOSTICO
Product type (English)
DIAGNOSTIC REAGENT
Registration information
Analysis ID
ee7d3c244e66268da2443fb5766cf537
Expire date
June 14, 2033
Authorized company / Fabricante
Name (English)
DISTRIBUTOR AND MARKETER DIZAR LTDA.
Product use / Uso del Producto
Spanish

ANTIBIOTIC DISC SON DISCOS DE PAPEL DE CARACTERÍSTICAS ESPECIALES, IMPREGNADOS CON UN ANTIBIÓTICO, UTILIZADOS PARA EL TEST DE_x000D_ SUSCEPTIBILIDAD SEGÚN EL TEST DE ANTIBIÓTICOS DE KIRBY.BAUER (TEST KB O TEST DE SENSIBILIDAD ANTIBIÓTICA POR DIFUSIÓN)._x000D_ ANTIBIOTIC DISC ESTÁN PREVISTOS EN UNA ANCHA VARIEDAD DE CONFIGURACIONES. CADA CONFIGURACIÓN ESTÁ DISPONIBLE EN LA VARIANTE_x000D_ DE 50 Y 250 TESTS

English

ANTIBIOTIC DISCS ARE PAPER DISCS WITH SPECIAL CHARACTERISTICS, IMPREGNATED WITH AN ANTIBIOTIC, USED FOR THE TEST DE_x000D_ SUSCEPTIBILITY ACCORDING TO KIRBY'S ANTIBIOTIC TEST. BAUER (KB TEST OR DIFFUSION ANTIBIOTIC SUSCEPTIBILITY TEST)._x000D_ ANTIBIOTIC DISCS ARE PROVIDED IN A WIDE VARIETY OF CONFIGURATIONS. EACH CONFIGURATION IS AVAILABLE IN THE VARIANTE_x000D_ FROM 50 TO 250 TESTS

About this record

Access comprehensive regulatory information for ANTIBIOTICOS AMINOGLUCOSIDOS: (AMINOGLYCOSIDE ANTIBIOTICS:) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID ee7d3c244e66268da2443fb5766cf537 and manufactured by DISTRIBUIDORA Y COMERCIALIZADORA DIZAR LTDA.. The device was registered on June 14, 2033.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.